These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35547829)

  • 1. Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?
    Li X; Yao Q; Liu C; Wang J; Zhang H; Li S; Cai P
    J Hepatocell Carcinoma; 2022; 9():379-387. PubMed ID: 35547829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and Prognostication of Gd-EOB-DTPA MRI and CT in Patients With Macrotrabecular-Massive Hepatocellular Carcinoma.
    Cheng J; Li X; Wang L; Chen F; Li Y; Zuo G; Pei M; Zhang H; Yu L; Liu C; Wang J; Han Q; Cai P; Li X
    J Magn Reson Imaging; 2024 Jun; 59(6):2071-2081. PubMed ID: 37840197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI imaging features for predicting macrotrabecular-massive subtype hepatocellular carcinoma: a systematic review and meta-analysis.
    Kim TH; Woo S; Lee DH; Do RK; Chernyak V
    Eur Radiol; 2024 Oct; 34(10):6896-6907. PubMed ID: 38507054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid-enhanced magnetic resonance imaging.
    Chen J; Xia C; Duan T; Cao L; Jiang H; Liu X; Zhang Z; Ye Z; Wu Z; Gao R; Shi Y; Song B
    Eur Radiol; 2021 Oct; 31(10):7696-7704. PubMed ID: 33856520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of computed tomography and magnetic resonance imaging findings and histopathological features of macrotrabecular-massive hepatocellular carcinoma.
    Gong Q; Zhang Y; Wu T; Du Z; Zhang Y
    Quant Imaging Med Surg; 2023 Jul; 13(7):4633-4640. PubMed ID: 37456331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
    Mulé S; Galletto Pregliasco A; Tenenhaus A; Kharrat R; Amaddeo G; Baranes L; Laurent A; Regnault H; Sommacale D; Djabbari M; Pigneur F; Tacher V; Kobeiter H; Calderaro J; Luciani A
    Radiology; 2020 Jun; 295(3):562-571. PubMed ID: 32228294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications.
    Rhee H; Cho ES; Nahm JH; Jang M; Chung YE; Baek SE; Lee S; Kim MJ; Park MS; Han DH; Choi JY; Park YN
    J Hepatol; 2021 Jan; 74(1):109-121. PubMed ID: 32818570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
    Zhang Y; He D; Liu J; Wei YG; Shi LL
    World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of imaging findings of macrotrabecular-massive hepatocellular carcinoma using CT and gadoxetic acid-enhanced MRI.
    Cha H; Choi JY; Park YN; Han K; Jang M; Kim MJ; Park MS; Rhee H
    Eur Radiol; 2023 Feb; 33(2):1364-1377. PubMed ID: 35999373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma.
    Zhu Y; Weng S; Li Y; Yan C; Ye R; Wen L; Zhou L; Gao L
    Abdom Radiol (NY); 2021 Jul; 46(7):3139-3148. PubMed ID: 33641018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma.
    Feng Z; Li H; Zhao H; Jiang Y; Liu Q; Chen Q; Wang W; Rong P
    Radiology; 2021 Jul; 300(1):219-229. PubMed ID: 33973839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corona enhancement combined with microvascular invasion for prognosis prediction of macrotrabecular-massive hepatocellular carcinoma subtype.
    Yang L; Wang M; Zhu Y; Zhang J; Pan J; Zhao Y; Sun K; Chen F
    Front Oncol; 2023; 13():1138848. PubMed ID: 36890813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gadoxetic acid-enhanced MRI-based multivariable model using LI-RADS v2018 and other imaging features for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma.
    Liang Y; Xu F; Wang Z; Tan C; Zhang N; Wei X; Jiang X; Wu H
    Eur J Radiol; 2022 Aug; 153():110356. PubMed ID: 35623312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.
    Ziol M; Poté N; Amaddeo G; Laurent A; Nault JC; Oberti F; Costentin C; Michalak S; Bouattour M; Francoz C; Pageaux GP; Ramos J; Decaens T; Luciani A; Guiu B; Vilgrain V; Aubé C; Derman J; Charpy C; Zucman-Rossi J; Barget N; Seror O; Ganne-Carrié N; Paradis V; Calderaro J
    Hepatology; 2018 Jul; 68(1):103-112. PubMed ID: 29281854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative prediction model for macrotrabecular-massive hepatocellular carcinoma based on contrast-enhanced CT and clinical characteristics: a retrospective study.
    He C; Zhang W; Zhao Y; Li J; Wang Y; Yao W; Wang N; Ding W; Wei X; Yang R; Jiang X
    Front Oncol; 2023; 13():1124069. PubMed ID: 37197418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypes and Tumor Immune Microenvironment in Hepatocellular Carcinoma With Macrotrabecular Massive and Vessels Encapsulating Tumor Clusters.
    Akiba J; Nakayama M; Kondo R; Kusano H; Ogasawara S; Mihara Y; Tanigawa M; Tsutsui K; Yano Y; Miyazaki D; Tokisawa S; Mitsuhashi T; Nomura H; Sanada S; Sakai H; Hisaka T; Yano H
    In Vivo; 2024; 38(2):640-646. PubMed ID: 38418151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS.
    Cannella R; Dioguardi Burgio M; Beaufrère A; Trapani L; Paradis V; Hobeika C; Cauchy F; Bouattour M; Vilgrain V; Sartoris R; Ronot M
    JHEP Rep; 2021 Dec; 3(6):100380. PubMed ID: 34825155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram for the Preoperative Prediction of the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
    Shan Y; Yu X; Yang Y; Sun J; Wu S; Mao S; Lu C
    J Hepatocell Carcinoma; 2022; 9():717-728. PubMed ID: 35974953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of strong invasive clinical features and poor prognosis in macrotrabecular-massive hepatocellular carcinoma].
    Shan YY; Wang CN; Mao SQ; Yu X; Sun JN; Lu CD
    Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1318-1325. PubMed ID: 38253077
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in hepatocellular carcinoma.
    Li XQ; Wang X; Zhao DW; Sun J; Liu JJ; Lin DD; Yang G; Liu H; Xia ZY; Jia CY; Li HJ
    World J Surg Oncol; 2020 Aug; 18(1):219. PubMed ID: 32828123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.